Merus Labs International Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 87   

Articles published

MSLI 2.52 +0.12 (5.00%)
price chart
Update on Merus Labs International, Athabasca Minerals Inc, Enghouse Systems ...
Contributing editor Ryan Irvine joins us this week with a detailed review of some of his previous recommendations. Ryan is the CEO of KeyStone Financial and one of the country's top experts in small cap stocks.
Merus Labs International Inc looks ready for more deals
But when it comes to specialty pharmaceutical company Merus Labs International Inc., it's hard not to expect more M&A.
3 NASDAQ Stocks See Large Decline in Short Interest: Merus Labs (NASDAQ:MSLI ...
Merus Labs International Inc (USA)(NASDAQ:MSLI) short interest dropped about -41.9%. According to wsj.com, some 382,608 shares in the stock were short as of 6/15/15, down from 658,065 on 5/29/15.
Merus Labs International Inc. Announces Aggregate $21 Million Financing ...
TORONTO, ONTARIO--(Marketwired - June 10, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today that the Company has entered into a private placement subscription agreement to ...
Related articles »  
Merus Labs International Inc adds to its unusual path with its largest equity ...
The creative history of Merus Labs International Inc. continued Monday when the now Toronto-based company announced a $60 million bought deal: the sale of 19.672 million shares at $3.05 a share.
Merus Labs International: A Pharma Stock With Growth Potential
It's Merus Labs International Inc. (TSX: MSL) (NASDAQ:MSLI), a specialty pharmaceutical company focused on acquiring established products.
Brokerages Set Merus Labs International Price Target at $3.83 (TSE:MSL)
Analysts at Laurentian raised their price target on shares of Merus Labs International from C$3.50 to C$3.75 and gave the company a “buy” rating in a research note on Monday, May 25th. Finally, analysts at Canaccord Genuity raised their price target on ...
Merus Labs International Inc. Announces Acquisition of Sintrom(R)
8, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce that one of its wholly owned subsidiaries has acquired from Novartis AG ("Novartis"), in certain European countries, the rights to ...
Merus Labs International (T.MSL) subsidiary buys rights to anticoagulant ...  Stockhouse
Related articles »  
Merus Labs International Inc. announces closing of c$60.0 million bought deal ...
TORONTO, April 30, 2015 /PRNewswire/ - Merus Labs International Inc. ("Merus" or the "Company") (TSX: MSL, NASDAQ: MSLI) is pleased to announce today the closing of its previously announced bought deal financing with a syndicate of investment dealers ...
Merus Labs International Coverage Initiated at TD Securities (MSL)
Equities research analysts at TD Securities assumed coverage on shares of Merus Labs International (TSE:MSL) in a research note issued to investors on Friday.
TD Securities Begins Coverage on Merus Labs International (MSLI)  The Legacy
Merus Labs International Research Coverage Started at TD Securities (MSL)  Mideast Time